Nav1.3 is a voltage-gated sodium channel alpha subunit encoded by SCN3A. It is highly expressed during cortical development and generally downregulated in adulthood, but can re-emerge in injury and hyperexcitable states.[@catterall2005][@waxman2006] This developmental-to-reactive expression profile makes Nav1.3 relevant to epilepsy, neurodevelopmental disorders, and injury-linked network dysfunction, with potential overlap in degenerative disease circuits.[@waxman2006][@zaman2018]
Channel Structure and Gating
Nav1.3 shares the canonical Nav topology: four six-segment domains, voltage-sensing S4 helices, and pore-forming S5-S6 loops with sodium selectivity.[@catterall2005][@catterall2012] Fast inactivation depends on the intracellular DIII-DIV linker motif, while slow inactivation and recovery kinetics influence repetitive firing behavior.[@catterall2012]
Compared with some adult-dominant isoforms, Nav1.3 can support rapid depolarizing currents that favor high excitability in immature neuronal networks.[@waxman2006]
Nav1.3 is a voltage-gated sodium channel alpha subunit encoded by SCN3A. It is highly expressed during cortical development and generally downregulated in adulthood, but can re-emerge in injury and hyperexcitable states.[@catterall2005][@waxman2006] This developmental-to-reactive expression profile makes Nav1.3 relevant to epilepsy, neurodevelopmental disorders, and injury-linked network dysfunction, with potential overlap in degenerative disease circuits.[@waxman2006][@zaman2018]
Channel Structure and Gating
Nav1.3 shares the canonical Nav topology: four six-segment domains, voltage-sensing S4 helices, and pore-forming S5-S6 loops with sodium selectivity.[@catterall2005][@catterall2012] Fast inactivation depends on the intracellular DIII-DIV linker motif, while slow inactivation and recovery kinetics influence repetitive firing behavior.[@catterall2012]
Compared with some adult-dominant isoforms, Nav1.3 can support rapid depolarizing currents that favor high excitability in immature neuronal networks.[@waxman2006]
Developmental Function
During prenatal and early postnatal periods, Nav1.3 participates in:
Immature cortical excitability programs.
Early axonal action potential conduction.
Activity-dependent maturation of local circuit timing.[@catterall2005][@waxman2006]
As Nav1.1 and Nav1.6 expression rises in maturation, Nav1.3 expression typically declines in many regions, shifting sodium-current composition toward adult firing phenotypes.[@waxman2006]
Disease Associations
SCN3A-Related Epileptic and Developmental Disorders
Pathogenic SCN3A variants can produce focal epilepsy, developmental delay, and cortical malformations. Gain-of-function variants are linked to increased persistent current and hyperexcitability; some loss-of-function variants are associated with distinct developmental phenotypes.[@zaman2018][@smith2019]
Acquired Hyperexcitability States
After CNS injury and in chronic pain models, re-expression of Nav1.3 has been reported and is associated with altered excitability thresholds.[@waxman2006][@hains2004] Although much work is preclinical, these findings support a model where Nav1.3 reactivation contributes to maladaptive firing patterns.
Alzheimer's Disease and Neurodegenerative Context
Definitive Nav1.3-causal data in [Alzheimer's disease](/diseases/alzheimers-disease) are limited, but sodium-channel remodeling and network hyperexcitability are recurrent themes in neurodegeneration. Nav1.3 is therefore best viewed as a candidate excitability amplifier rather than a primary degenerative trigger.[@vossel2013][@palop2016]
Therapeutic Considerations
Current sodium channel blockers are usually non-selective across Nav isoforms. This creates a translational challenge: suppressing pathological Nav1.3 activity without impairing other channels required for normal cognition and motor function.[@catterall2012][@hains2004]
Potential future directions include:
Isoform-biased sodium channel modulators.
Variant-specific precision treatment in SCN3A channelopathies.
Biomarker-guided use of antiseizure therapies in mixed neurodevelopmental-neurodegenerative phenotypes.[@zaman2018][@smith2019]
Evidence Strength and Gaps
Evidence is strongest for SCN3A variants in epilepsy/developmental disorders and moderate for Nav1.3 re-expression in injury models. Evidence in chronic neurodegeneration remains inferential and needs targeted mechanistic studies.[@zaman2018][@vossel2013]
Key gaps:
Human longitudinal data linking Nav1.3 shifts to cognitive decline trajectories.
Cell-type-specific mapping of Nav1.3 in glia-neuron inflammatory states.
Trial-ready biomarkers for Nav1.3-dominant excitability phenotypes.
See Also
[Nav1.1 Sodium Channel Protein](/proteins/nav1-1)
[Nav1.6 Protein (SCN8A)](/proteins/nav1-6-protein)
[Catterall WA, Goldin AL, Waxman SG, International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels (2005)](https://pubmed.ncbi.nlm.nih.gov/17157348/)
[Waxman SG, Hains BC, Fire and phantoms after spinal cord injury: Na+ channel expression and reorganization (2006)](https://pubmed.ncbi.nlm.nih.gov/16460884/)
[Zaman T, Helbig I, Bozovic IB, et al, Mutations in SCN3A cause early infantile epileptic encephalopathy (2018)](https://pubmed.ncbi.nlm.nih.gov/29373653/)
[Catterall WA, Voltage-gated sodium channels at 60: structure, function and pathophysiology (2012)](https://pubmed.ncbi.nlm.nih.gov/25287849/)
[Smith RS, Florio M, Akula SK, et al, SCN3A-related neurodevelopmental disorder: a spectrum of epilepsy and brain malformation (2019)](https://pubmed.ncbi.nlm.nih.gov/30929737/)
[Hains BC, Saab CY, Waxman SG, Changes in electrophysiological properties and sodium channel expression after injury (2004)](https://pubmed.ncbi.nlm.nih.gov/15254035/)
[Vossel KA, Beagle AJ, Rabinovici GD, et al, Seizures and epileptiform activity in early Alzheimer's disease (2013)](https://pubmed.ncbi.nlm.nih.gov/25088910/)
[Palop JJ, Mucke L, Network abnormalities and interneuron dysfunction in Alzheimer disease (2016)](https://pubmed.ncbi.nlm.nih.gov/25201513/)